» Articles » PMID: 15517334

Immunolocalization of Protein 4.1B/DAL-1 During Neoplastic Transformation of Mouse and Human Intestinal Epithelium

Overview
Publisher Springer
Date 2004 Nov 2
PMID 15517334
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, we have reported that the protein 4.1B immunolocalization occurred only in matured columnar epithelial cells of normal rat intestines. This finding suggested that protein 4.1B expression could be examined for a possible change during neoplastic transformation of the intestinal mucosa. In the present study, we first present the distribution of mouse protein 4.1B in normal intestinal epithelial cells and tumor cells using the adenomatous polyposis coli (Apc) mutant mouse model. A low level of protein 4.1B expression coincided with the phenotypic transition to carcinoma. To examine the protein 4.1B expression in human intestinal mucosa, we used another antibody against an isoform of the human protein 4.1B, DAL-1 (differentially expressed adenocarcinoma of the lung). Human DAL-1 was also expressed in matured epithelial cells in human colons, with a definite expression gradient along the crypt axis. In human colorectal cancer cells, however, DAL-1 expression was not detected. These results suggest that mouse protein 4.1B and human DAL-1 might have a striking analogy of functions, which may be integrally involved in epithelial proliferation. We propose that loss of protein 4.1B/DAL-1 expression might be a marker of intestinal tumors, indicative of a tumor suppressor function in the intestinal mucosa.

Citing Articles

Cytological DNA methylation for cervical cancer screening: a validation set.

Kong L, Wang L, Wang Z, Xiao X, You Y, Wu H Front Oncol. 2023; 13:1181982.

PMID: 37671063 PMC: 10475939. DOI: 10.3389/fonc.2023.1181982.


The rs9953490 polymorphism of DAL-1 gene is associated with gastric cancer risk in the Han population in Northeast China.

Wang H, Jiang Y, Yu L, Xu L, Guan R, Cai M BMC Gastroenterol. 2021; 21(1):354.

PMID: 34579655 PMC: 8477503. DOI: 10.1186/s12876-021-01929-9.


4.1B suppresses cancer cell proliferation by binding to EGFR P13 region of intracellular juxtamembrane segment.

Xue F, An C, Chen L, Liu G, Ren F, Guo X Cell Commun Signal. 2019; 17(1):115.

PMID: 31492173 PMC: 6731589. DOI: 10.1186/s12964-019-0431-6.


4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.

Yang Q, Zhu M, Wang Z, Li H, Zhou W, Xiao X Tumour Biol. 2016; 37(9):12713-12723.

PMID: 27448302 DOI: 10.1007/s13277-016-5146-3.


Immunohistochemical study of the membrane skeletal protein, membrane protein palmitoylated 6 (MPP6), in the mouse small intestine.

Kamijo A, Saitoh Y, Ohno N, Ohno S, Terada N Histochem Cell Biol. 2015; 145(1):81-92.

PMID: 26496923 DOI: 10.1007/s00418-015-1374-7.


References
1.
Gutmann D, Hirbe A, Huang Z, Haipek C . The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion. Neurobiol Dis. 2001; 8(2):266-78. DOI: 10.1006/nbdi.2000.0376. View

2.
Tran Y, Bogler O, Gorse K, Wieland I, Green M, Newsham I . A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer. Cancer Res. 1999; 59(1):35-43. View

3.
Giles R, van Es J, Clevers H . Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta. 2003; 1653(1):1-24. DOI: 10.1016/s0304-419x(03)00005-2. View

4.
Takakuwa Y . Protein 4.1, a multifunctional protein of the erythrocyte membrane skeleton: structure and functions in erythrocytes and nonerythroid cells. Int J Hematol. 2001; 72(3):298-309. View

5.
Yu Y, Khan J, Khanna C, Helman L, Meltzer P, Merlino G . Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med. 2004; 10(2):175-81. DOI: 10.1038/nm966. View